Detalhe da pesquisa
1.
Stem cell mobilization in multiple myeloma patients relapsing after previous autologous hematopoietic stem cell transplantation: A multicenter report by the Polish Myeloma Study Group.
J Clin Apher
; 36(3): 443-453, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33592119
2.
The efficacy and safety of pomalidomide in relapsed/refractory multiple myeloma in a "real-world" study: Polish Myeloma Group experience.
Eur J Haematol
; 101(3): 354-361, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29882602
3.
Metformin - its potential anti-cancer and anti-aging effects.
Postepy Hig Med Dosw (Online)
; 71(0): 170-175, 2017 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28258677
4.
Final overall survival results of a randomized trial comparing bortezomib plus pegylated liposomal doxorubicin with bortezomib alone in patients with relapsed or refractory multiple myeloma.
Cancer
; 122(13): 2050-6, 2016 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27191689
5.
PTK2 expression and immunochemotherapy outcome in chronic lymphocytic leukemia.
Blood
; 124(3): 420-5, 2014 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-24916506
6.
Danazol induces apoptosis and cytotoxicity of leukemic cells alone and in combination with purine nucleoside analogs in chronic lymphocytic leukemia.
Ann Hematol
; 95(3): 425-35, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26692089
7.
Bortezomib, thalidomide and dexamethasone, with or without cyclophosphamide, for patients with previously untreated multiple myeloma: 5-year follow-up.
Br J Haematol
; 171(3): 344-54, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26153365
8.
Inactivation of TP53 correlates with disease progression and low miR-34a expression in previously treated chronic lymphocytic leukemia patients.
Blood
; 121(18): 3650-7, 2013 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-23525797
9.
Assessing the efficacy of allogeneic hematopoietic stem cells transplantation (allo-HSCT) by analyzing survival end points in defined groups of acute myeloid leukemia patients: a retrospective, multicenter Polish Adult Leukemia Group study.
Am J Hematol
; 90(10): 904-9, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26149802
10.
The rate of in vitro fludarabine-induced peripheral blood and bone marrow cell apoptosis may predict the chemotherapy outcome in patients with chronic lymphocytic leukemia.
Eur J Clin Pharmacol
; 71(9): 1121-7, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26141594
11.
Altered plasma fibrin clot properties and fibrinolysis in patients with multiple myeloma.
Eur J Clin Invest
; 44(6): 557-66, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24738991
12.
Safety of bosutinib versus imatinib in the phase 3 BELA trial in newly diagnosed chronic phase chronic myeloid leukemia.
Am J Hematol
; 89(10): 947-53, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24944159
13.
The VEGF receptor, neuropilin-1, represents a promising novel target for chronic lymphocytic leukemia patients.
Int J Cancer
; 133(6): 1489-96, 2013 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23447383
14.
Circulating microenvironment of CLL: are nurse-like cells related to tumor-associated macrophages?
Blood Cells Mol Dis
; 50(4): 263-70, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23313631
15.
Aberrant TIRAP and MyD88 expression in B-cell chronic lymphocytic leukemia.
Blood Cells Mol Dis
; 51(1): 48-55, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23419703
16.
Additional genetic abnormalities significantly worsen poor prognosis associated with 1q21 amplification in multiple myeloma patients.
Hematol Oncol
; 31(1): 41-8, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22674819
17.
Immune thrombocytopenia in patients with chronic lymphocytic leukemia treated with cladribine-based regiments or chlorambucil--follow-up of PALG-CLL randomized trials.
Eur J Haematol
; 91(1): 1-9, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23521128
18.
Decitabine improves response rate and prolongs progression-free survival in older patients with newly diagnosed acute myeloid leukemia and with monosomal karyotype: A subgroup analysis of the DACO-016 trial.
Am J Hematol
; 93(5): E125-E127, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29417613
19.
Bendamustine as monotherapy and in combination regimens for the treatment of chronic lymphocytic leukemia and non-hodgkin lymphoma: a retrospective analysis.
Chemotherapy
; 59(4): 280-9, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24457828
20.
TLR2 may influence the behavior of the malignant clone in B-CLL.
Blood Cells Mol Dis
; 49(1): 32-40, 2012 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22521894